decabromobiphenyl ether has been researched along with Hyperglycemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koike, E; Takano, H; Win-Shwe, TT; Yanagisawa, R | 1 |
Gu, J; Qiu, LL; Sun, ZZ; Wang, SL; Wang, X; Wang, XC; Xiao, X; Xu, Q; Zhang, XH; Zhang, Z; Zhen, B; Zhou, S | 1 |
2 other study(ies) available for decabromobiphenyl ether and Hyperglycemia
Article | Year |
---|---|
Decabromodiphenyl ether exacerbates hyperglycemia in diet-induced obese mice.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Flame Retardants; Glucose; Glucose Transporter Type 4; Halogenated Diphenyl Ethers; Hyperglycemia; Insulin; Male; Mechanistic Target of Rapamycin Complex 2; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Thyroid Hormone Receptors alpha | 2019 |
Mechanism of BDE209-induced impaired glucose homeostasis based on gene microarray analysis of adult rat liver.
Topics: Animals; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Halogenated Diphenyl Ethers; Homeostasis; Hyperglycemia; Lipid Metabolism; Liver; Male; Metabolic Networks and Pathways; Microarray Analysis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2013 |